中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
7期
577-580
,共4页
王淑梅%孙路路%曾蔚欣%章国良
王淑梅%孫路路%曾蔚訢%章國良
왕숙매%손로로%증위흔%장국량
急性淋巴细胞白血病%细胞色素P450 2 C19%甲氨蝶呤%血清浓度
急性淋巴細胞白血病%細胞色素P450 2 C19%甲氨蝶呤%血清濃度
급성림파세포백혈병%세포색소P450 2 C19%갑안접령%혈청농도
acute lymphoblastic leukemia%cytochrome P450 2C19%methotrexate%serum concentration
目的:考察CYP2C19*2(G681A)和CYP2C19*3(G636A)基因多态性与急性淋巴细胞白血病( ALL)易感性及甲氨蝶呤( MTX)血清浓度的相关性。方法收集283名健康对照受试者和91例ALL患儿的外周血,提取DNA。用聚合酶链反应-限制性片断长度多态性法检测CYP2C19*2和CYP2C19*3基因型,用荧光偏振免疫分析法测定24,42 h MTX血清浓度。结果 ALL患儿与健康对照人群的CYP2C19*2和CYP2C19*3基因型与等位基因分布频率相近,与野生等位基因相比,变异等位基因( A )降低了ALL的发病风险,但差异无统计学意义。 CYP2C19*2和CYP2C19*3各基因型组的ALL患儿于24,42 h MTX浓度与剂量比值( C/D ratio)比较,差异无统计学意义。结论 CYP2C19*2和CYP2C19*3基因多态性与ALL的发病风险和MTX血清浓度无明显相关性。
目的:攷察CYP2C19*2(G681A)和CYP2C19*3(G636A)基因多態性與急性淋巴細胞白血病( ALL)易感性及甲氨蝶呤( MTX)血清濃度的相關性。方法收集283名健康對照受試者和91例ALL患兒的外週血,提取DNA。用聚閤酶鏈反應-限製性片斷長度多態性法檢測CYP2C19*2和CYP2C19*3基因型,用熒光偏振免疫分析法測定24,42 h MTX血清濃度。結果 ALL患兒與健康對照人群的CYP2C19*2和CYP2C19*3基因型與等位基因分佈頻率相近,與野生等位基因相比,變異等位基因( A )降低瞭ALL的髮病風險,但差異無統計學意義。 CYP2C19*2和CYP2C19*3各基因型組的ALL患兒于24,42 h MTX濃度與劑量比值( C/D ratio)比較,差異無統計學意義。結論 CYP2C19*2和CYP2C19*3基因多態性與ALL的髮病風險和MTX血清濃度無明顯相關性。
목적:고찰CYP2C19*2(G681A)화CYP2C19*3(G636A)기인다태성여급성림파세포백혈병( ALL)역감성급갑안접령( MTX)혈청농도적상관성。방법수집283명건강대조수시자화91례ALL환인적외주혈,제취DNA。용취합매련반응-한제성편단장도다태성법검측CYP2C19*2화CYP2C19*3기인형,용형광편진면역분석법측정24,42 h MTX혈청농도。결과 ALL환인여건강대조인군적CYP2C19*2화CYP2C19*3기인형여등위기인분포빈솔상근,여야생등위기인상비,변이등위기인( A )강저료ALL적발병풍험,단차이무통계학의의。 CYP2C19*2화CYP2C19*3각기인형조적ALL환인우24,42 h MTX농도여제량비치( C/D ratio)비교,차이무통계학의의。결론 CYP2C19*2화CYP2C19*3기인다태성여ALL적발병풍험화MTX혈청농도무명현상관성。
Objective To investigate the associations between CYP2C19*2 (G681A) and CYP2C19*3 (G636A) polymorphisms with the risk to develop acute lymphoblastic leukemia ( ALL ) and serum concentra-tions of methotrexate ( MTX).Methods Peripheral blood samples were obtained from healthy subjects as control samples ( n=283 ) and children with acute lymphoblastic leukemia ( n =91 ) to extract genome DNA.Polymerase chain reaction-restriction fragment length polymorphism was used to detect the genotypes of CYP2C19*2 and CYP2C19*3 polymor-phisms.Fluorescence polarization immunoassay was employed to deter-mine the serum concentrations of MTX at the time of 24 h and 42 h.Results There were similar frequencies of genotypes and alleles at CYP2 C19*2 and CYP2 C19*3 in healthy subjects and ALL children.Compared with wid alleles , variant alleles ( A) lowered the risk of ALL , but there was no statistical difference.There were no significant differ-ences in the dose-adjusted serum concentration ( C/D ratio) of MTX at the 24 h and 42 h among respective genotype groups at CYP2 C19*2 and CYP2C19*3.Conclusion CYP2C19*2 and CYP2C19*3 polymorphisms are not associated with the risk to develop ALL and serum concentrations of MTX.